Evidence map›Paper›PMID 40258860›Full record

ArticleScientific reports2025

Comparative statistical evaluation of greenness, blueness, and whiteness spectrophotometric methods for dexamethasone and chloramphenicol estimation.

Heidi R Abd El-Hadi

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Heidi R Abd El-HadiFaculty of Pharmacy, Pharmaceutical Chemistry Department, Egyptian Russian University, Badr City, Cairo, Egypt. heidi-abdelhadi@eru.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five sustainable and validated UV spectrophotometric methods were developed for analyzing chloramphenicol (CHL) and dexamethasone sodium phosphate (DSP) in pure and ophthalmic dosage forms. CHL was detected by zero order spectra method at 292.0 nm in the range 2.00-32.00 µg/mL with limits of detection (LOD) and quantification (LOQ) of 0.96 and 2.88, respectively. DSP was analyzed using the following four techniques: Induce dual wavelength (IDW), fourier self-deconvolution (FSD), ratio difference (RD), and derivative ratio (DD

Indexed as

ChloramphenicolDexamethasoneLimit of DetectionSpectrophotometrySpectrophotometry, UltravioletChloramphenicolDexamethasoneBluenessChloramphenicolDexamethasone sodium phosphateGreennessSpectrophotometric methodsWhiteness

Identifiers

PMID40258860
PMCPMC12012086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.